Figure 7. Upregulation of ARHGEF11 in human HCC patients predicted poor survival outcomes. Kaplan-Meier curve about OS (A) and DFS (B) of patients from West China hospital dataset based on ARHGEF11 high and ARHGEF11 low expression. (C) Kaplan-Meier curve about OS of patients with BCLC 0/A classification from West China hospital dataset based on ARHGEF11 high and ARHGEF11 low expression. (D) Nomogram for OS that integrated ARHGEF11 expression levels, tumor size and BCLC classification. (E–G) Calibration curve for predicting patients’ survival at 1 year, 3 year and 5 year respectively.